Table 3.

Relevant acute respiratory infections.

Respiratory infections [number (%) of patients]	Total n = 51	Patients on 4-week regimen, n = 48	Patients on 3-week regimen, n = 3
Patients with an AE marked as respiratory
ARIs	40(78·4%)	38(79·2%)	2(66·7%)
Bronchitis	16(31·4%)	14(29·2%)	2(66·7%)
Sinusitis	11(21·6%)	10(20·8%)	1(33·3%)
Respiratory tract infection	11(21·6%)	11(22·9%)	0
Rhinitis	9(17·6%)	8(16·7%)	1(33·3%)
Pharyngitis	9(17·6%)	8(16·7%)	1(33·3%)
Pneumonia	4(7·8%)	4(8·3%)	0
Tracheitis	2(3·9%)	2(4·2%)	0
Chronic bronchitis	2(3·9%)	2(4·2%)	0
Chronic obstructive pulmonary disease	1(2·9%)	1(2·1%)	0

AE, adverse event; ARI, acute and relevant infection.